Alkermes plc
US ˙ NasdaqGS ˙ IE00B56GVS15

Introduction

This page provides a comprehensive analysis of the known insider trading history of Mark Stejbach. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Mark Stejbach has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:FLXN / Horizon Funds - Horizon Flexible Income ETF Director 0
US:ALKS / Alkermes plc SVP/Chief Comm Off, Alks Inc 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Mark Stejbach. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ALKS / Alkermes plc - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ALKS / Alkermes plc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2012-11-13 ALKS Stejbach Mark 1,200 20.1300 1,200 20.1300 24,156 365 37.5500 20,904 86.54

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ALKS / Alkermes plc Insider Trades
Insider Sales ALKS / Alkermes plc - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ALKS / Alkermes plc. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ALKS / Alkermes plc Insider Trades
Insider Purchases FLXN / Horizon Funds - Horizon Flexible Income ETF - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ALKS / Alkermes plc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2020-05-26 FLXN Stejbach Mark 2,051 9.7500 2,051 9.7500 19,997 65 13.8500 8,409 42.05
2017-06-16 FLXN Stejbach Mark 1,580 17.0178 1,580 17.0178 26,888

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

FLXN / Horizon Funds - Horizon Flexible Income ETF Insider Trades
Insider Sales FLXN / Horizon Funds - Horizon Flexible Income ETF - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ALKS / Alkermes plc. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

FLXN / Horizon Funds - Horizon Flexible Income ETF Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Mark Stejbach as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -7,000 0 -100.00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -7,000 0 -100.00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -12,500 0 -100.00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -12,500 0 -100.00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -12,500 0 -100.00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -25,000 0 -100.00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -12,631 0 -100.00 8.50 -107,364
2021-06-28 2021-06-24 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
A - Award 7,000 7,000
2021-06-28 2021-06-24 4 FLXN Flexion Therapeutics Inc
Common Stock
A - Award 4,500 12,631 55.34
2020-06-12 2020-06-10 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
A - Award 7,000 7,000
2020-06-12 2020-06-10 4 FLXN Flexion Therapeutics Inc
Common Stock
A - Award 4,500 6,551 219.41
2020-05-27 2020-05-26 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 2,051 2,051 9.75 19,997 19,997
2019-06-21 2019-06-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
A - Award 12,500 12,500
2018-06-21 2018-06-20 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
A - Award 12,500 12,500
2018-03-05 2018-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,813 0 -100.00
2018-03-05 2018-03-03 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -1,251 51,065 -2.39 60.05 -75,123 3,066,453
2018-03-05 2018-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,813 52,316 5.68
2018-03-05 2018-03-01 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -5,250 10,500 -33.33
2018-03-05 2018-03-01 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -2,334 49,503 -4.50 57.41 -133,995 2,841,967
2018-03-05 2018-03-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 5,250 51,837 11.27
2018-02-28 2018-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,625 2,625 -50.00
2018-02-28 2018-02-26 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -1,167 46,587 -2.44 58.12 -67,826 2,707,636
2018-02-28 2018-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,625 47,754 5.82
2018-02-28 2018-02-23 4 ALKS Alkermes plc.
Ordinary Shares
G - Gift -1,000 45,129 -2.17
2018-02-21 2018-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -3,000 9,000 -25.00
2018-02-21 2018-02-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -884 46,129 -1.88 67.26 -59,458 3,102,637
2018-02-21 2018-02-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 3,000 47,013 6.82
2018-02-21 2018-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 13,500 13,500
2018-02-21 2018-02-16 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 54,500 54,500
2018-02-21 2018-02-16 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -10,880 5,780 -65.31
2018-02-21 2018-02-16 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -10,880 44,013 -19.82 70.50 -767,092 3,103,128
2018-02-21 2018-02-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 10,880 54,893 24.72 17.30 188,224 949,649
2017-07-27 2017-06-22 4 FLXN Flexion Therapeutics Inc
Stock Option (Right to Buy)
A - Award 12,500 12,500
2017-06-20 2017-06-16 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 1,580 1,580 17.02 26,888 26,888
2017-06-08 2017-06-08 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -10,000 16,660 -37.51
2017-06-08 2017-06-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -10,000 44,013 -18.51 60.34 -603,352 2,655,533
2017-06-08 2017-06-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 10,000 54,013 22.72 17.30 173,000 934,425
2017-05-30 2017-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,500 0 -100.00
2017-05-30 2017-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,500 44,013 6.02
2017-03-06 2017-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,812 2,813 -49.99
2017-03-06 2017-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,812 41,513 7.27
2017-03-02 2017-03-01 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -5,250 15,750 -25.00
2017-03-02 2017-03-01 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -2,437 38,701 -5.92 59.71 -145,513 2,310,837
2017-03-02 2017-03-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 5,250 41,138 14.63
2017-02-27 2017-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,625 5,250 -33.33
2017-02-27 2017-02-26 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -852 35,888 -2.32 52.98 -45,139 1,901,346
2017-02-27 2017-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,625 36,740 7.69
2017-02-21 2017-02-17 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 50,000 50,000
2017-02-21 2017-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 12,000 12,000
2017-01-10 2017-01-09 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -547 26,660 -2.01
2017-01-10 2017-01-09 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -547 34,115 -1.58 60.27 -32,968 2,056,111
2017-01-10 2017-01-09 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 547 34,662 1.60 17.30 9,463 599,653
2017-01-06 2017-01-06 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -6,653 27,207 -19.65
2017-01-06 2017-01-06 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -6,653 34,115 -16.32 60.07 -399,643 2,049,274
2017-01-06 2017-01-06 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 6,653 40,768 19.50 17.30 115,097 705,286
2017-01-06 2017-01-05 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -300 33,860 -0.88
2017-01-06 2017-01-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -300 34,115 -0.87 60.09 -18,026 2,049,854
2017-01-06 2017-01-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 300 34,415 0.88 17.30 5,190 595,380
2017-01-06 2017-01-04 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -2,500 34,160 -6.82
2017-01-06 2017-01-04 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -2,500 34,115 -6.83 60.01 -150,018 2,047,139
2017-01-06 2017-01-04 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 2,500 36,615 7.33 17.30 43,250 633,440
2016-11-14 2016-11-10 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -5,780 36,660 -13.62
2016-11-14 2016-11-10 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes X -1,692 34,115 -4.73 59.07 -99,946 2,015,173
2016-11-14 2016-11-10 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 5,780 35,807 19.25 17.30 99,994 619,461
2016-10-06 2016-10-05 4 ALKS Alkermes plc.
Performance Restricted Stock Units
M - Exercise -5,000 0 -100.00
2016-10-06 2016-10-05 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -1,623 30,027 -5.13 46.43 -75,356 1,394,154
2016-10-06 2016-10-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 5,000 31,650 18.76
2016-09-14 2016-09-13 4 FLXN Flexion Therapeutics Inc
Stock Option (right to buy)
A - Award 25,000 25,000
2016-06-01 2016-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,500 2,500 -50.00
2016-06-01 2016-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,500 26,650 10.35
2016-03-04 2016-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,813 5,625 -33.34
2016-03-04 2016-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,813 24,150 13.18
2016-03-01 2016-02-29 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 21,000 21,000
2016-03-01 2016-02-29 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 85,000 85,000
2016-03-01 2016-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,625 7,875 -25.00
2016-03-01 2016-02-26 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -852 21,337 -3.84 33.61 -28,636 717,137
2016-03-01 2016-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,625 22,189 13.42
2015-12-28 2015-12-28 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -10,000 42,440 -19.07
2015-12-28 2015-12-28 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -10,000 19,564 -33.82 80.24 -802,392 1,569,800
2015-12-28 2015-12-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 10,000 29,564 51.11 17.30 173,000 511,457
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -18,000 52,440 -25.55
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -500 19,564 -2.49 73.58 -36,791 1,439,558
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -2,300 20,064 -10.28 73.09 -168,105 1,466,460
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -15,200 22,364 -40.46 71.99 -1,094,313 1,610,081
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 18,000 37,564 92.01 17.30 311,400 649,857
2015-11-12 2015-11-05 4 ALKS Alkermes plc.
Ordinary Shares
G - Gift -400 19,564 -2.00
2015-11-04 2015-11-02 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -18,000 70,440 -20.35
2015-11-04 2015-11-02 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -2,330 19,964 -10.45 72.51 -168,939 1,447,514
2015-11-04 2015-11-02 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -15,670 22,294 -41.28 72.00 -1,128,229 1,605,152
2015-11-04 2015-11-02 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 18,000 37,964 90.16 17.30 311,400 656,777
2015-10-07 2015-10-05 4 ALKS Alkermes plc.
Performance Restricted Stock Units
A - Award 5,000 5,000
2015-10-07 2015-10-05 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -1,676 19,964 -7.74 59.77 -100,175 1,193,248
2015-10-07 2015-10-05 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 5,000 21,640 30.05
2015-05-29 2015-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,500 5,000 -33.33
2015-05-29 2015-05-28 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -813 16,640 -4.66 59.92 -48,715 997,069
2015-05-29 2015-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,500 17,453 16.72
2015-04-17 2015-04-15 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -5,780 88,440 -6.13
2015-04-17 2015-04-15 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes X -1,591 14,953 -9.62 62.83 -99,963 939,497
2015-04-17 2015-04-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 5,780 16,544 53.70 17.30 99,994 286,211
2015-03-05 2015-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,812 8,438 -25.00
2015-03-05 2015-03-03 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -914 10,764 -7.83 72.80 -66,539 783,619
2015-03-05 2015-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,812 11,678 31.72
2015-02-27 2015-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 10,500 10,500
2015-02-27 2015-02-26 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 44,000 44,000
2014-05-30 2014-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -2,500 7,500 -25.00
2014-05-30 2014-05-28 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -814 8,866 -8.41 45.74 -37,232 405,531
2014-05-30 2014-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,500 9,680 34.82
2014-03-05 2014-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 11,250 11,250
2014-03-05 2014-03-03 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 50,000 50,000
2014-01-17 2014-01-15 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise -2,780 94,220 -2.87
2014-01-17 2014-01-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 2,780 7,180 63.18 17.30 48,094 124,214
2013-12-27 2013-12-26 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise -3,000 97,000 -3.00
2013-12-27 2013-12-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 3,000 4,400 214.29 17.30 51,900 76,120
2013-05-29 2013-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 10,000 10,000
2013-05-29 2013-05-28 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 70,000 70,000
2012-11-19 2012-11-13 4 ALKS Alkermes plc.
Ordinary Shares
P - Purchase 1,200 1,400 600.00 20.13 24,156 28,182
2012-03-09 2012-03-07 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 100,000 100,000
2012-03-05 3 ALKS Alkermes plc.
Common Stock
200
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)